JORDAN SPENCER: Open Payments
NPI 1851886782 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,966 in 245 payments from 25 companies in 2025. Trend: 2023 $857 · 2024 $2,960 · 2025 $57,966
Honoraria: $46,475Food & beverage: $4,513Travel & lodging: $3,428Speaker / faculty: $2,550Consulting: $1,000
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 84 | $51,098 |
| Alkermes, Inc. | 17 | $3,847 |
| ABBVIE INC. | 34 | $612 |
| Vanda Pharmaceuticals Inc. | 23 | $576 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $311 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Otsuka America Pharmaceutical, Inc. | 7 | $158 |
| Lundbeck LLC | 10 | $158 |
| Janssen Pharmaceuticals, Inc | 9 | $140 |
| Teva Pharmaceuticals USA, Inc. | 6 | $113 |
Products named: Auvelity, VIVITROL, HETLIOZ, VRAYLAR, SPRAVATO, CAPLYTA, REXULTI, ARISTADA.
Industry payments across SC — which companies pay providers there.
